Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

German Multicenter Trial for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years With Rituximab for Improvement of Prognosis in CD20 Positive Standard Risk ALL (Amend 2)

NCT00199004 is registered in ClinicalTrials.gov with Johann Wolfgang Goethe University Hospital as lead sponsor.

NCT NCT00199004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00199004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
German Multicenter Trial for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years With Rituximab for Improvement of Prognosis in CD20 Positive Standard Risk ALL (Amend 2)
Lead sponsor
Johann Wolfgang Goethe University Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
March 31, 2009
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute lymphocytic leukemia